These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 7872065

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H, Spinner D, Reddy GS, Lindley IJ.
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H, Kurian SM, Hendy GN, White J, deLuca HF, Evans CO, Nanes MS.
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [Abstract] [Full Text] [Related]

  • 9. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
    Pramanik R, Asplin JR, Lindeman C, Favus MJ, Bai S, Coe FL.
    Cell Immunol; 2004 Jun; 232(1-2):137-43. PubMed ID: 15876428
    [Abstract] [Full Text] [Related]

  • 10. Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter.
    Morrison N, Eisman J.
    J Bone Miner Res; 1993 Aug; 8(8):969-75. PubMed ID: 8213259
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transcriptional activation of the human osteocalcin gene by basic fibroblast growth factor.
    Schedlich LJ, Flanagan JL, Crofts LA, Gillies SA, Goldberg D, Morrison NA, Eisman JA.
    J Bone Miner Res; 1994 Feb; 9(2):143-52. PubMed ID: 8140927
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture.
    Hale LV, Kemick ML, Wuthier RE.
    J Bone Miner Res; 1986 Dec; 1(6):489-95. PubMed ID: 3509742
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. DNA sequences downstream from the vitamin D response element of the rat osteocalcin gene are required for ligand-dependent transactivation.
    Sneddon WB, Bogado CE, Kiernan MS, Demay MB.
    Mol Endocrinol; 1997 Feb; 11(2):210-7. PubMed ID: 9013768
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activity of ornithine decarboxylase and creatine kinase in soft and hard tissue of vitamin D-deficient chicks following parenteral application of 1,25-dihydroxyvitamin D3 or 24R,25-dihydroxyvitamin D3.
    Ittel TH, Ross FP, Norman AW.
    J Bone Miner Res; 1986 Feb; 1(1):23-31. PubMed ID: 3509739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.